Richard Marshak
Corporate Officer/Principal at TRISALUS LIFE SCIENCES, INC.
Net worth: 270 602 $ as of 2024-04-29
Profile
Dr. Richard B.
Marshak is a Senior VP-Corporate Development & Strategy at TriSalus Life Sciences, Inc. and a Director & Chief Business Officer at Nephraegis Therapeutics, Inc. He is on the Board of Directors at Nephraegis Therapeutics, Inc. Dr. Marshak was previously employed as a Chief Executive Officer & Director by Mount TAM Biotechnologies, Inc., a President & Principal by LF Consulting, and a General Manager-Alliance Management by Abbott Laboratories.
He received his undergraduate degree from the University of Pennsylvania and an MBA from The University of Chicago Booth School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-02-11 | 27,251 ( 0.10% ) | 270 602 $ | 2024-04-29 |
Richard Marshak active positions
| Companies | Position | Start |
|---|---|---|
| TRISALUS LIFE SCIENCES, INC. | Corporate Officer/Principal | 2023-08-09 |
Nephraegis Therapeutics, Inc.
 Nephraegis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nephraegis Therapeutics, Inc. is a biopharmaceutical company that focuses on developing a family of proprietary drug candidates to prevent and treat acute kidney injury (AKI). The company is based in Lake Forest, IL. The company's lead compound, NPH-022, is an epoxyeicosatrienoic-related compound (EET) with optimized pharmacokinetic properties. The CEO of the company is Bryan F. Cox. | Founder | 2018-08-31 |
Former positions of Richard Marshak
| Companies | Position | End |
|---|---|---|
LF Consulting
 LF Consulting Miscellaneous Commercial ServicesCommercial Services LF Consulting specializes in data management and analysis. The private company is based in Sherwood, OR. The company's services include obtaining, transforming, processing, and visualizing data to help clients make informed decisions. | President | 2022-05-31 |
Mount TAM Biotechnologies, Inc.
 Mount TAM Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Mount TAM Biotechnologies, Inc. is a biopharmaceutical company, which engages in the development of therapeutic products for targeting systemic lupus erythematosus ("SLE"). It also focuses in the discovery and development of novel mTOR inhibitors, with specific emphasis on developing compounds with unique mTORC1:mTORC2 inhibitory profiles. The company was founded by Chester P. Aldridge in November 2011 and is headquartered in Burlington, VT. | Chief Executive Officer | 2019-09-30 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 2012-12-31 |
Training of Richard Marshak
| University of Pennsylvania | Undergraduate Degree |
| The University of Chicago Booth School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| TRISALUS LIFE SCIENCES, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Mount TAM Biotechnologies, Inc.
Mount TAM Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Mount TAM Biotechnologies, Inc. is a biopharmaceutical company, which engages in the development of therapeutic products for targeting systemic lupus erythematosus ("SLE"). It also focuses in the discovery and development of novel mTOR inhibitors, with specific emphasis on developing compounds with unique mTORC1:mTORC2 inhibitory profiles. The company was founded by Chester P. Aldridge in November 2011 and is headquartered in Burlington, VT. | Health Technology |
LF Consulting
LF Consulting Miscellaneous Commercial ServicesCommercial Services LF Consulting specializes in data management and analysis. The private company is based in Sherwood, OR. The company's services include obtaining, transforming, processing, and visualizing data to help clients make informed decisions. | Commercial Services |
Nephraegis Therapeutics, Inc.
Nephraegis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nephraegis Therapeutics, Inc. is a biopharmaceutical company that focuses on developing a family of proprietary drug candidates to prevent and treat acute kidney injury (AKI). The company is based in Lake Forest, IL. The company's lead compound, NPH-022, is an epoxyeicosatrienoic-related compound (EET) with optimized pharmacokinetic properties. The CEO of the company is Bryan F. Cox. | Health Technology |
- Stock Market
- Insiders
- Richard Marshak
